Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus ropivacaine thoracic paravertebral block for analgesia after thoracoscopic lobectomy
ChiCTR2100044003Phase 4Recruiting
- Sponsor
- Rizhao People's Hospital
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esketamine and ropivacaine in postoperative pain (3 arms), sponsored by Rizhao People's Hospital. Primary endpoints: Time to complete ultrasound-guided thoracic paravertebral nerve block, Blood pressure and 13 more. Started Jan 2021; status: recruiting.
02
Drugs
esketamineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2100044003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044003.